Trajan Innovation Fund is a unique initiative to provide funding for targeted research to address identified needs to improve human wellbeing using innovative technologies.
Learn more about commercial opportunities for academia.
ARC CPTT - ARC Training Centre for Personalised Therapeutics Technologies aims to advance and deploy new technologies that will remove long-standing barriers to new drug discovery and development, and excitingly, provide opportunities for highly effective personalised treatments.
Headquartered at the Department of Pharmacology and Therapeutics at the University of Melbourne, the center brings together the University of Melbourne, Monash University, University of Western Australia, and 17 partner organizations in government and industry.
ARC CPTT is training a new generation of enterprizing biomedical researchers. It aims to transform the medical technologies and pharmaceutical (MTP) industry’s access to emergent technologies that enable accelerated translation of discoveries into benefits for end users.
The University of Tasmania (UTAS) is Trajan's founding academic partner in ASTech.
The University of South Australia (UniSA) became an ASTech academic partner in 2016.
LaTrobe University became an ASTech academic partner in 2017.
Trajan’s strategic collaboration with the University of Adelaide's Institute for Photonics and Advanced Sensing is supported by the South Australian Government, and sees the realization of a research and development and manufacturing hub based on a new generation of specialty glass products for the global science and medical equipment market.
Trajan has engaged in various projects with the Australian Centre for Research on Separation Science (ACROSS), a strategic alignment among key researchers at the University of Tasmania, RMIT University and the University of Western Sydney.
The first Trajan Innovation Fund program was established for researchers based at the ACROSS at the University of Tasmania (UTAS), Australia.
Monash University attended a workshop at Trajan to discuss collaborative projects in developing new advanced manufacturing techniques.
Monash Histology Platform
Monash Histology Platform (MHP) is a world class, full service histology laboratory. Trajan is working with MHP to better understand how microscope slide design and surface treatments can impact the quality of the diagnostic process.
By leveraging MHP's expertise in a wide range of histological techniques, Trajan's microscope slides can be independently evaluated for efficacy of cell adhesion for 'difficult to process' tissue such as breast, skin and bone samples.
Trajan identified unique technology, equipment and technical talent at the University of South Australia (UniSA) that would benefit the mass spectrometer electrospray market. Trajan has worked closely with the Future Industries Institute (FII) at UniSA on prototyping, and scaling a range of resultant products for manufacture for to service the global market. The project was partly funded by an FII Accelerator grant supported by the South Australian Government.
Trajan is also working with FII on microbiopsy development.
Trajan and Queen’s University (Queens), Kingston, Canada, via PARTEQ Innovations, the University’s technology transfer organization; and Université Laval’s Center for Optics, Photonics and Lasers (COPL), Québec City, Canada; are collaborating to develop the next generation of emitter tips for the mass spectrometry industry.
Trajan has facilitated student placements as part of RMIT's Bachelor of Biotechnology. For example, one project focused on developing faster analysis in proteomics by a novel approach to immobilize proteins or enzymes on a solid support prior to in-line analysis using an HPLC-MS system.
Trajan is pleased to collaborate with the Faculty of Science at the University of Melbourne to support industry projects offered to final year students enrolled in the Master of Biotechnology. For example, one project delves into the pros and cons of adopting whole slide imaging (WSI) and digital pathology.